Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints – PharmaLive
Teva Pharmaceuticals to pay $4.2 billion opioid settlement; New York to get $523 million - CBS New York
64 Teva Pharmaceutical Industries Images, Stock Photos & Vectors | Shutterstock
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Analysts Split Over Buffett's Backing of Teva Pharma | BioSpace
Teva overhauls its board again, and almost all its old-timers are gone | Fierce Pharma
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical revenue by region 2018-2022 | Statista
Teva Pharmaceuticals Acquisition – PL Developments
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
Teva, one of the biggest generic makers, joins the the brand-name club
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceuticals Archives - The Qualitalks Podcast
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development
